In March, Dongtou, an island city in Wenzhou, Zhejiang, swept away the haze of the epidemic and was full of spring. The newly built and put into use "Corporate Culture Landscape Pool" by Zhejiang Cheng Yi Pharmaceutical Co., Ltd. shines brightly under the sunlight, this reflects the firm confidence of the "Cheng Yi people" in running the marine medicine industry well.
From a small workshop style family factory to the first listed pharmaceutical company in Wenzhou and the first listed marine biopharmaceutical company in Zhejiang, Cheng Yi Pharmaceutical has developed into a well-known enterprise in China's marine biopharmaceutical industry.
In the future, Cheng Yi Pharmaceutical will continue to embark on a path of development for pharmaceutical enterprises with island characteristics, Wenzhou characteristics, and Chinese characteristics.
On May 13, 2022, Yuan Jiajun, former Secretary of the Zhejiang Provincial Party Committee, visited Cheng Yi Pharmaceutical for inspection and research, saying, "There is great potential for developing the marine economy, especially in the high-end industry chain of marine biopharmaceuticals. We must adhere to the innovation driven development strategy, strengthen the deep integration of industry, academia, and research, continue to increase research and development investment, and promote the continuous strengthening and expansion of the marine biopharmaceutical industry
Broad observation and appointment, thick accumulation and thin hair. Cheng Yi Pharmaceutical, which is launching a sprint towards the goal of a century old pharmaceutical enterprise, is continuing to write a new "legend" of China's marine medicine.
Marching into the National Market from "Imitation" to "Research and Innovation"
Relying on the advantages of Dongtou as a demonstration zone for marine economic development, Cheng Yi Pharmaceutical has been deeply cultivating marine biopharmaceuticals for many years. Driven by innovation, based on talent, and guided by the market, it is strengthening its research capabilities and accelerating its march from the "generic drug stage" to the "innovative drug stage".
It is reported that Cheng Yi Pharmaceutical's fish oil soft capsule health food, which has been listed, has conducted research and development of raw materials and formulations while applying for and registering health products, and has increased the EPA content of fish oil to over 98%.
On September 19, 2022, Ding Jian, an academician of the CAE Member who came to Dongtou for research and research, said to the company's "research and innovation project as a special technical guidance," This is my second time to come to Dongtou, and Cheng Yi Pharmaceutical has changed a lot. Since the outbreak of the epidemic, many domestic enterprises have been greatly impacted, but Cheng Yi Pharmaceutical has been moving up, which shows that the product is excellent and the market is rigid. "
As Ding Jian said. Quality drives brand, brand drives market.
If we are to move from "imitation" to "research and innovation", it is a sincere effort by Cheng Yi Pharmaceutical to research and improve technology, and to "collaborate" with Maiken Pharmaceutical (Dalian) Co., Ltd., which will open up a new situation for its comprehensive expansion of the terminal market sales of national drug glucosamine hydrochloride capsules (hereinafter referred to as "aminoglucose capsules").
At present, Cheng Yi Pharmaceutical's ammonia sugar capsule products have unique advantages such as full industry chain, full specifications, high purity, and no excipients, making them the largest sales volume of similar products in China. Both parties have signed a "Medium to Long Term Marketing Strategic Cooperation Agreement for Some Product Specifications of Amino Sugar Capsules", planning to further expand the market through strategic cooperation, complementary advantages, product promotion, and brand promotion.
We have confidence and determination to further promote Cheng Yi Pharmaceutical Amino Sugar Capsules to the national market, strengthen and expand, and establish our brand through advertising and brand marketing models, "said Ma Yunpeng, General Manager of Maiken Pharmaceutical (Dalian) Co., Ltd. at the signing ceremony.
Behind the rapid development of our career, we cannot do without investment in infrastructure construction. 3 fish oil extraction workshops, 1 traditional Chinese medicine extraction workshop, 1 traditional Chinese medicine decoction workshop, 2 Class C warehouses, tank farms and power centers, expert buildings
In August 2021, Cheng Yi Pharmaceutical acquired 106 acres of land and launched the second phase of the "Health Industry Park" construction, with marine biopharmaceuticals, traditional Chinese medicine, and other main development directions, radiating and driving the transformation and upgrading of the health industry in Dongtou as a national marine economic development demonstration zone. At present, the second phase of the civil engineering project has been completed, and the fish oil workshop has synchronously completed the equipment installation and started trial production.
"At the beginning of last year, we invested over 6 million yuan in upgrading the waste gas treatment system and built a 'organic waste gas treatment thermal storage high-temperature oxidation furnace', with a treatment effect of over 98% and a heat recovery efficiency of over 95%. It was rated as a Wenzhou municipal environmental protection technology demonstration project. "Zhao Chunjian, General Manager of Cheng Yi Pharmaceutical, said," Only by leading the safety and environmental protection work of industrial enterprises can we enable them to go further and further on the path of high-quality development. "
At the same time, Cheng Yi Pharmaceutical has invested over 1 million yuan to build the "Smart Energy Management System", which adopts automation, informatization, visualization, and centralized management modes to monitor and analyze the energy consumption status of each workshop in real-time, comprehensively achieving dynamic monitoring and digital management, providing strong guarantees for the enterprise to achieve energy conservation, consumption reduction, and green development.
In October 2022, Cheng Yi Pharmaceutical was listed as one of the first batch of key chemical monitoring points in Zhejiang Province, making it the only industrial enterprise in the Wenzhou region and laying a solid foundation for future projects and long-term development.
Steadily advancing into the "big health industry" and building a pharmaceutical highland
The "Fish Oil Soft Capsule Health Food" has passed the on-site inspection of the production license by the Zhejiang Provincial Market Supervision Administration; Obtaining the first "Health Food Production License" in Wenzhou, becoming the first health food production enterprise in Wenzhou, achieving a "breakthrough of zero" in the production of health food in Wenzhou
After successfully launching the traditional Chinese medicine decoction piece "Dendrobium officinale powder", Cheng Yi Pharmaceutical entered the year 2022, relying on its geographical advantage of "based in Wenzhou and facing the sea", focusing on the opportunities for the health product industry to flourish, and advancing towards the "big health industry" can be described as "everything is ready".
In July 2022, Cheng Yi Pharmaceutical completed the registration of two fish oil soft capsule products for domestic health food and obtained the registration certificate for domestic health food issued by the State Administration for Market Regulation.
The formal production of the company's health food soft capsule workshop will be conducive to further expanding the company's product categories, enriching the company's product line, enhancing the company's health food field, in line with the company's strategic plan to layout the 'big health industry', and laying a foundation for the company's sustainable development, "said Zhao Chunjian, General Manager of Cheng Yi Pharmaceutical.
In addition to fish oil soft capsules, Cheng Yi Pharmaceutical is promoting the commercialization and industrialization of multiple "health series products". Drugs and health foods represented by Dendrobium officinale have been successfully developed and listed in its Yunnan subsidiary; The ultrahigh purity "nervonic acid" soft capsule developed and produced to protect brain health has been successfully trial produced, and has a clear curative effect on patients with Parkinson's disease.
At the same time, it is planning more than 10 "health series products", and the "Cheng Yi section" of the "big health industry" has quietly taken shape.
Realizing the layout of the entire process, category, and industry chain from food to health products to pharmaceuticals is an innovative move by Cheng Yi Pharmaceutical to seize the strategic high ground of biopharmaceuticals and empower enterprises with new value. It is also a "Cheng Yi force" that focuses on building the "aircraft carrier" of Zhejiang Southern Medicine and contributes to accelerating the construction of Zhejiang Marine Economic Development Demonstration Zone
The signing of the "first order" for the industrialization of scientific and technological achievements with the Zhejiang Subtropical Crop Research Institute (hereinafter referred to as the "Subtropical Crop Institute") has become a strong proof. In August 2022, Cheng Yi Pharmaceutical signed a cooperation agreement with the Asia Research Institute for "Seven Patents and Four Technologies" of "Cicada Flower Cordyceps".
Chai Yiqiu, the leader of the entomogenous fungi discipline at the Subtropical Crop Institute, introduced that "Cicada Flower Cordyceps" is known as the "Cordyceps sinensis" in the south, with a medicinal record of 1500 years. It has functions such as improving immunity, improving eyesight, protecting liver, anti kidney failure, analgesia, sedation, anti-tumor, and lowering blood sugar and blood pressure.
After more than a year of communication and investigation between the two parties in the early stage, Cheng Yi Pharmaceutical has conducted in-depth research on the safety and effectiveness of "Cicada Flower Cordyceps" and decided to collaborate with the Subtropical Crop Institute to develop a series of health product capsules, medicinal liquor, medicinal tea, and other products of "Cicada Flower Cordyceps". It plans to settle the project in the "Health Industry Park Phase II".
Collaborating with Cheng Yi Pharmaceutical to develop the 'Cicada Flower Cordyceps' series of products is a great joy for the Subtropical Crop Institute in 40 years. Wang Cailian, Vice Mayor of Wenzhou, hopes that both parties can make the' Cicada Flower Cordyceps Project 'bigger and stronger, and make more contributions to building a' life and health highland 'for Wenzhou and even Zhejiang.
Coming from the blue sea, with self-improvement and a sense of responsibility as the style... Starting from the "two big vats", the island enterprise has gone through more than 50 years of baptism, and Cheng Yi Pharmaceutical has once again stood at a new starting point of leapfrog development. Looking ahead to the future, its wish to "sincerely reach the world and benefit people's livelihoods" is gradually becoming a reality.
（Originally published in "China News" on March 6th, by Shi Zinan）